We are live on
!
Find out more
DCM
Driehaus Capital Management Portfolio holdings
AUM
$13.6B
1-Year Est. Return
173.98%
This Fund
S&P 500
This Quarter
Est. Return
+16.2%
1 Year Est. Return
+173.98%
3 Year Est. Return
+706.72%
5 Year Est. Return
+1,585.86%
10 Year Est. Return
+31,592.09%
AUM
$6.6B
AUM Growth
+$430M
(+7%)
Cap. Flow
+$25.1M
Cap. Flow
% of AUM
0.38%
Top 10 Holdings %
Top 10 Hldgs %
17.96%
Holding
434
New
82
Increased
115
Reduced
129
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Calix
CALX
|
+$48.2M |
| 2 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$44.8M |
| 3 |
Wingstop
WING
|
+$42.6M |
| 4 |
EPAM Systems
EPAM
|
+$40M |
| 5 |
RB Global
RBA
|
+$38.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$75.3M |
| 2 |
FIVE9
FIVN
|
+$40.4M |
| 3 |
AAR Corp
AIR
|
+$34.3M |
| 4 |
DigitalOcean
DOCN
|
+$32.2M |
| 5 |
XPeng
XPEV
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.47% |
| 2 | Technology | 20.32% |
| 3 | Industrials | 15.76% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Consumer Staples | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
W.R. Berkley
WRB
$26.7B
| $5.82M | 0.09% |
135,242
-413,598
| -75% | -$18M |
|
|
TPIC
252
DELISTED
TPI Composites
TPIC
| $5.81M | 0.09% |
+515,366
| New | +$8.15M |
|
253
XPO
XPO
$23.1B
| $5.77M | 0.09% |
218,135
| – | – |
|
254
A10 Networks
ATEN
$2.16B
| $5.75M | 0.09% |
433,271
-3,250
| -0.7% | -$46.2K |
|
255
OrthoPediatrics
KIDS
$536M
| $5.75M | 0.09% |
+124,584
| New | +$6.11M |
|
256
Acumen Pharmaceuticals
ABOS
$157M
| $5.73M | 0.09% |
+571,424
| New | +$3.28M |
|
257
Molson Coors Class B
TAP
$7.86B
| $5.71M | 0.09% |
118,945
+22,245
| +23% | +$1.21M |
|
258
Harley-Davidson
HOG
$2.66B
| $5.67M | 0.09% |
162,642
-72,291
| -31% | -$2.71M |
|
259
Boot Barn
BOOT
$4.8B
| $5.56M | 0.08% |
95,055
-169,732
| -64% | -$11.4M |
|
260
Crocs
CROX
$6.47B
| $5.54M | 0.08% |
+80,699
| New | +$5.6M |
|
261
Designer Brands
DBI
$331M
| $5.46M | 0.08% |
356,958
-521,225
| -59% | -$8.17M |
|
262
Federal Signal
FSS
$7.88B
| $5.44M | 0.08% |
+145,740
| New | +$5.73M |
|
|
PHLT
263
DELISTED
Performant Healthcare Inc
PHLT
| $5.39M | 0.08% |
2,915,392
-131,921
| -4% | -$307K |
|
264
C4 Therapeutics
CCCC
$387M
| $5.32M | 0.08% |
606,721
+9,347
| +2% | +$97K |
|
265
CTS Corp
CTS
$1.86B
| $5.29M | 0.08% |
+126,982
| New | +$5.1M |
|
|
IMGO
266
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $5.17M | 0.08% |
343,846
-8,809
| -2% | -$143K |
|
267
AtriCure
ATRC
$1.97B
| $5.16M | 0.08% |
131,955
-89,688
| -40% | -$4.1M |
|
|
SPNE
268
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $5.16M | 0.08% |
907,707
-21,772
| -2% | -$138K |
|
|
VECT
269
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $5.13M | 0.08% |
854,735
-10,494
| -1% | -$57K |
|
270
Helmerich & Payne
HP
$3.41B
| $5.12M | 0.08% |
138,557
-376,542
| -73% | -$15.8M |
|
|
ZING
271
DELISTED
FTAC Zeus Acquisition Corp. Class A Common Stock
ZING
| $5.03M | 0.08% |
500,000
| – | – |
|
272
Albertsons Companies
ACI
$5.58B
| $4.88M | 0.07% |
+196,109
| New | +$5.35M |
|
|
THRN
273
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
| $4.83M | 0.07% |
1,020,098
-26,131
| -2% | -$131K |
|
|
RGF
274
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
| $4.73M | 0.07% |
61,009
-1,561
| -2% | -$127K |
|
|
CLAS
275
DELISTED
Class Acceleration Corp.
CLAS
| $4.69M | 0.07% |
475,000
| – | – |
|
Similar funds
CC
PMAM
SA
PSCM
WHG
AA
WA
SAM
Driehaus Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Driehaus Capital Management held 434 positions worth $6.6B, up 7% from $6.17B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Driehaus Capital Management's Q3 2022 filing shows 82 new, 115 increased, 129 reduced and 91 closed positions. Its largest new stake was Axonics, Inc. Common Stock: 648,976 shares worth $45.7M. The largest sale was Pfizer, an estimated $75.3M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.
- Driehaus Capital Management's largest Q3 2022 buy was Axonics, Inc. Common Stock: 648,976 shares worth $45.7M.
- Driehaus Capital Management added most to Calix in Q3 2022, an estimated $48.2M increase.
- Driehaus Capital Management's biggest Q3 2022 reduction was HDFC Bank, cutting an estimated $30M.
- Driehaus Capital Management fully exited Pfizer in Q3 2022, selling an estimated $75.3M.
- Driehaus Capital Management's ten largest holdings make up 18% of its $6.6B portfolio in Q3 2022.
- Driehaus Capital Management opened 82 new positions and closed 91 in Q3 2022.
- Driehaus Capital Management's portfolio value rose 7% quarter-over-quarter to $6.6B.
Based on Driehaus Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.